Heart


Now Playing

No shows for this artist currently listed in Currentland.
 

Currentland News and Reviews

Heart, Alan Jackson heat up The Joint
[February 2014] - The Hard Rock Hotel & Casino always brings the best in nationally touring acts to their uniquely arranged auditorium known as The Joint. With a stellar sound system and wonderful lines of sight to the stage for all patrons, you can’t find a better venue for a big name act.   read more...
Two casinos’ events worth checking in Currentland in September
There are many casinos in our area that have entertainment worth checking out, but we were quite excited about September’s line-up at Downstream and River Spirit in Tulsa for September. It’s worth noting that both of these concerts are early in the month, so time is of the essence.   read more...
Doin’ it at Downstream
Ever feel like you need to get out of Oklahoma once in a while for a good time? Well the Downstream Casino ain’t quite outta state, but it’s outta sight if you’re into catching some live music action. And it’s just a stone’s throw from Missouri, where they sell whiskey at Wal-Mart seven days a week.   read more...

Recent News For This Artist

Heart drug launch could be 'most exciting ever', says Novartis
The expected launch of Novartis's new heart failure drug next year promises to be the company's most exciting ever and profit margins on the medicine will be good, its head of pharmaceuticals said on Sunday. The Swiss drugmaker impressed doctors at the European Society of Cardiology meeting in Barcelona at the weekend by unveiling strikingly good clinical trial results for the drug, known as ... read more...
Study: Novel heart failure drug shows big promise
A new study reports one of the biggest potential advances against heart failure in more than a decade ??? a first-of-a-kind, experimental drug that lowered the chances of death or hospitalization by about 20 percent. read more...
New Novartis drug may upend heart failure treatment
* Drug cuts cardiovascular death, hospitalisations by fifth * Has been little progress in heart failure in past decade * Novartis sees multibillion-dollar sales opportunity * Glowing review of drug in New England Journal of Medicine (Adds further comment from investigators, reaction) read more...
Novartis Heart Failure Drug Tops Standard in Study
Novartis AG (NOVN) ???s experimental heart failure drug kept more patients in a study from dying or being hospitalized than the standard therapy, a result that could transform treatment of the disease that afflicts 26 million people worldwide. read more...
 
dummy